Expression and Function of TNF α cDNA mutant in human bladder cancer EJ cell lines
Qin Dashan
Abstract
Qin Dashan
Abstract
Objective To study the function of a gene mutant of tumor necrosis factor α (TNF α) in bladder cancer. Methods A TNF α cDNA mutant was selected as the target gene.The novel mutant was transduced into human bladder cancer EJ cell lines with the plasmid pcDNA 3.1(+) as the vector by the method of calcium phosphate DNA coprecipitation. Results Polymerase chain reaction (PCR) analysis confirmed the exogenic gene was stably integrated into EJ cell lines.The level of TNF α in the supernatant collected from EJ cells transfected with TNF α cDNA mutant was (0.664±0.225)ng/ml by radioimmunoassay (RIA) and L929 bioassay showed its cytotoxicity was 4~8U/ml.The formation ability of clony in soft agar was decreased significantly and the inhibition rate was 36.5%. Conclusions The TNF α cDNA mutant can be used in gene therapy for bladder cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the function of a gene mutant of tumor necrosis factor α (TNF α) in bladder cancer. Methods A TNF α cDNA mutant was selected as the target gene.The novel mutant was transduced into human bladder cancer EJ cell lines with the plasmid pcDNA 3.1(+) as the vector by the method of calcium phosphate DNA coprecipitation. Results Polymerase chain reaction (PCR) analysis confirmed the exogenic gene was stably integrated into EJ cell lines.The level of TNF α in the supernatant collected from EJ cells transfected with TNF α cDNA mutant was (0.664±0.225)ng/ml by radioimmunoassay (RIA) and L929 bioassay showed its cytotoxicity was 4~8U/ml.The formation ability of clony in soft agar was decreased significantly and the inhibition rate was 36.5%. Conclusions The TNF α cDNA mutant can be used in gene therapy for bladder cancer.
Key concepts: Complementary DNA, Mutant, Molecular biology, Transfection, Cell culture, Gene, Tumor necrosis factor alpha, Plasmid